P04.1
Newborn affected by other maternal medication
P04.1 is a non-billable ICD-10-CM code header for newborn affected by other maternal medication. Report a more specific code from it instead. It is part of the FY2027 code set, effective October 1, 2026. The more specific codes under it are P04.11 Newborn affected by maternal antineoplastic chemotherapy, P04.12 Newborn affected by maternal cytotoxic drugs, P04.13 Newborn affected by maternal use of anticonvulsants, P04.14 Newborn affected by maternal use of opiates and 6 more. Its coding notes include a Code first instruction, 2 Excludes1 entries and 11 Excludes2 entries.
Guidelines tip
From the FY2027 Official Guidelines. ICD10Ref adds no rules of its own.
Chapter 16 codes are never used on the maternal record, and chapter 15 codes are never used on the newborn record. Chapter 16 codes can be used for life if the condition persists.
Code first
If the underlying condition listed here is present and known, sequence it first.
- any current condition in newborn, if applicable
Excludes1
Not coded here. The listed conditions generally should not be reported together.
Excludes2
Not included here. Both codes may be reported if the patient has both conditions.
- congenital malformations (Q00-Q99)
- encounter for observation of newborn for suspected diseases and conditions ruled out (Z05.-)
- neonatal jaundice from excessive hemolysis due to drugs or toxins transmitted from mother (P58.4)
- newborn in contact with and (suspected) exposures hazardous to health not transmitted via placenta or breast milk (Z77.-)
Also from chapter/block level (5 notes)
- congenital malformations, deformations and chromosomal abnormalities (Q00-Q99)
- endocrine, nutritional and metabolic diseases (E00-E88)
- injury, poisoning and certain other consequences of external causes (S00-T88)
- neoplasms (C00-D49)
- tetanus neonatorum (A33)
Includes
Further defines or gives examples of the content of the category.
- nonteratogenic effects of substances transmitted via placenta
Also from chapter/block level (1 note)
- conditions that have their origin in the fetal or perinatal period (before birth through the first 28 days after birth) even if morbidity occurs later
Notes
Also from chapter/block level (2 notes)
- These codes are for use when the listed maternal conditions are specified as the cause of confirmed morbidity or potential morbidity which have their origin in the perinatal period (before birth through the first 28 days after birth).
- Codes from this chapter are for use on newborn records only, never on maternal records
More specific codes under P04.1 10
- P04.11Newborn affected by maternal antineoplastic chemotherapyBillable
- P04.12Newborn affected by maternal cytotoxic drugsBillable
- P04.13Newborn affected by maternal use of anticonvulsantsBillable
- P04.14Newborn affected by maternal use of opiatesBillable
- P04.15Newborn affected by maternal use of antidepressantsBillable
- P04.16Newborn affected by maternal use of amphetaminesBillable
- P04.17Newborn affected by maternal use of sedative-hypnoticsBillable
- P04.1ANewborn affected by maternal use of anxiolyticsBillable
- P04.18Newborn affected by other maternal medicationBillable
- P04.19Newborn affected by maternal use of unspecified medicationBillable